【ChiCTR2200062460】Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
ChiCTR2200062460
尚未开始
/
/
/
2022-08-08
/
/
Mild-moderate depression and anxiety
Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
The primary objective is to: 1. Evaluate the feasibility and acceptability of the online IMMP by measuring recruitment feasibility, intervention adherence, dropout, participants self-rated satisfaction/engagement/ perceived difficulty/helpfulness of the IMMP intervention, and adverse events. The secondary objectives are to provide: 2. Preliminary efficacy of IMMP on depression and anxiety, negative and positive affect, meaning in life, and mindfulness, to provide useful sample size calculation reference for future full RCTs. 3. Qualitative feedbacks on the IMMP for improvement.
随机平行对照
探索性研究/预试验
Stratified block randomization using a block of 8 will be applied to enhance the balance of age, gender, and depression/anxiety severity level between groups. The randomization procedure will be conducted by an independent statistician using computer program.
Due to the nature of the intervention, it is impossible to blind participants, but the investigators and persons who conduct the statistical analyses will be blinded to treatment allocation.
Health and Medical Research Fund, Food and Health Bureau, HKSAR
/
40
/
2022-08-26
2023-07-25
/
1) Adults aged 18 or above in Hong Kong; 2) With PHQ-9 and/or GAD-7 scores at 5-14 which suggested mild to moderate depression and/or anxiety levels; 3) No regular practice of mindfulness meditation; and 4) Willing to complete the 8 weekly online interventions.;
请登录查看1) Suicidal ideation, plans or behaviours, as they may need more intensive clinical care; 2) Cannot understand Chinese as the programmes will be conducted in Chinese; 3) No WhatsApp account as the intervention will be sent through WhatsApp - a popular instant messenger in Hong Kong; and 4) Other conditions rendering them incapable of following in the 8-week online interventions (e.g., vision and hearing problems).;
请登录查看JC School of Public Health and Primary Care, The Chinese University of Hong Kong
/
JC School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
JC School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验
- Personalised Lifestyle Medicine in Mid-life Project
- Effects of Behavioural Activation With Mindfulness and Physical Exercise (BAMPE) on Mental Health: A Randomized Controlled Trial
- Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial
- 慢性腰背痛症者對靜觀治療的支付意願和偏好
- Online integrated mindfulness-meaning programme for depression and anxiety during COVID-19: A pilot randomized controlled trial
- 專科門診病人經驗調查 2018/19
- 對香港自閉症譜系兒童及其家庭進行正念訓練改善其健康狀况
- 正念认知疗法治疗自杀幸存者预试验
- 兩個临床證據質量評估工具的可靠性比較:隨機對照試驗
- 以社區為基礎的隊列研究 - 使用全自動視網膜圖像分析(ARIA)來評估中風風險與生活方式的關系
- Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

